Cardiac Safety Services Market: Innovations in Monitoring Technologies

The global cardiac safety services market was valued at approximately USD 972.3 million in 2024 and is anticipated to grow to USD 1,924.3 million by 2030, reflecting a compound annual growth rate (CAGR) of 12.1% from 2025 to 2030. This growth is driven by the increasing prevalence of cardiovascular diseases, regulatory mandates, the rising complexity of clinical trials, and an enhanced focus on personalized medicine.

According to the British Heart Foundation's 2024 report, around 620 million people worldwide suffer from heart and circulatory diseases, a number that continues to rise due to changing lifestyles and an aging population.

Given these trends, the global prevalence of cardiovascular conditions remains significant, affecting approximately 1 in 13 individuals globally. High-quality data collection and reporting are essential for informed decision-making throughout all phases of drug development. Accurate cardiac safety data is crucial for early identification of potential risks, optimization of clinical trial designs, and assurance of the safety of new therapies. The demand for reliable and precise data to support regulatory submissions and secure market approvals is increasing, propelling the need for specialized cardiac safety services. Companies require advanced technologies and expertise to effectively gather and analyze cardiac data, thereby fostering a robust market for these services.

Cardiovascular diseases (CVDs) remain the leading cause of mortality globally, significantly impacting health systems. The World Heart Federation reported that CVDs were responsible for 20.5 million deaths in 2021, accounting for nearly one-third of all global fatalities. This high prevalence generates substantial demand for cardiac safety services, as both patients and healthcare providers seek to mitigate the risks associated with cardiovascular interventions and treatments. As the global population ages and lifestyle-related risk factors such as obesity and diabetes become more common, the necessity for effective cardiac safety monitoring and management systems increases.

Key Market Trends & Insights

• Market Dominance in North America: The North American cardiac safety services market held the largest revenue share of 63.6% in 2024, largely due to the high prevalence of cardiovascular diseases (CVDs). The American Heart Association estimates that 82.6 million individuals in the U.S. are affected by some form of CVD, creating a strong demand for advanced cardiac monitoring and safety services.
• S. Market Characteristics: The U.S. market is distinguished by its advanced healthcare infrastructure, high incidence of cardiovascular diseases, and significant investments in medical research and technology. The American Heart Association indicates that heart disease is the leading cause of death in the U.S., further driving the need for comprehensive cardiac safety solutions.
• Service Segment Leadership: The ECG/Holter monitors segment led the market with a revenue share of 41.0% in 2024. These devices are essential for continuous cardiac monitoring, allowing for real-time detection of arrhythmias, ischemic episodes, and other cardiovascular conditions. Their widespread use is attributed to their effectiveness in providing detailed and continuous heart rate data, which is vital for accurate data collection.
• Integrated Segment Dominance: The integrated segment achieved the largest revenue share of 63.0% in 2024, driven by the increasing demand for comprehensive, multi-functional cardiac monitoring solutions that enhance accuracy, efficiency, and patient convenience.
• Pharma & Biopharma Segment Leadership: The pharma and biopharma segment led the market with a 44.0% revenue share in 2024, primarily due to the sector's significant involvement in developing and clinically testing cardiovascular drugs and therapies, which necessitates thorough cardiac safety assessments.

**** 

Order a free sample PDF of the Carbon Accounting Software Market Intelligence Study, published by Grand View Research.

**** 

Market Size & Forecast

• 2024 Market Size: USD 972.3 Million
• 2030 Projected Market Size: USD 1,924.3 Million
• CAGR (2025-2030): 12.1%
• North America: Largest market in 2024

**** 

Key Companies & Market Share Insights

The market is dominated by several companies that collectively account for a significant market share. These leading players established themselves through extensive research and development efforts, resulting in the introduction of innovative services. They also expanded their service portfolios through strategic collaborations, mergers, and acquisitions.

**** 

Key Players

• Medpace
• IQVIA
• PPD Inc.,
• Charles River Laboratories
• Wuxi AppTec
• Eurofins Scientific
• Celerion
• Nova Research Laboratories
• Laboratory Corporation of America Holdings
• Koninklije Philips N.V.
• ICON Plc.
• SGS S.A.
• Clario
• Certara
• Richmond Pharmacology
• Biotrial

**** 

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

**** 

Conclusion

The global cardiac safety services market is poised for substantial growth, driven by the rising prevalence of cardiovascular diseases and the increasing complexity of clinical trials. The demand for high-quality cardiac safety data is paramount for effective drug development and regulatory compliance. As healthcare systems worldwide grapple with the burden of cardiovascular diseases, the need for specialized cardiac safety services will continue to grow, presenting opportunities for innovation and investment in this critical sector. Leading companies are likely to enhance their market positions through research and development, strategic collaborations, and the introduction of innovative services.